Mark T. Butt

2.0k citations

62 papers · 1.3k indexed · h-index 22

Impact in

Small Animals top 1%
- Animal testing and alternatives
Developmental Neuroscience top 5%

Papers in ⓘ

Small Animals 12
- Animal testing and alternatives 11
Developmental Neuroscience 4

Co-authors: Brad Bolon (10 shared papers)Alys Bradley (5 shared papers)Robert H. Garman (5 shared papers)Ingrid D. Pardo (5 shared papers)Karl F. Jensen (5 shared papers)Robert B. Boyd (8 shared papers)Robert C. Sills (4 shared papers)G. Krinke (6 shared papers)
Journals: Toxicologic Pathology (19 papers)Regulatory Toxicology and Pharmacology (4 papers)Toxicological Sciences (3 papers)Journal of the American Veterinary Medical Association (2 papers)PLoS ONE (2 papers)
Partner nations: United States United Kingdom Australia

In The Last Decade

Mark T. Butt

60 papers receiving 1.2k citations

Peers

Countries citing papers authored by Mark T. Butt

Since Specialization

Citations

This map shows the geographic impact of Mark T. Butt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark T. Butt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark T. Butt more than expected).

Fields of papers citing papers by Mark T. Butt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark T. Butt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark T. Butt. The network helps show where Mark T. Butt may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark T. Butt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark T. Butt Line = papers co-authored together Mark T. Butt links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 62 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	STP Position Paper Toxicologic Pathology ·Brad Bolon, Robert H. Garman, Ingrid D. Pardo, Karl F. Jensen, Robert C. Sills, Aude Roulois, Ann Radovsky, Alys Bradley, Lydia Andrews-Jones, Mark T. Butt, Laura A. Gumprecht	2013	122
2	Proliferative and Nonproliferative Lesions of the Rat and Mouse Central and Peripheral Nervous Systems Toxicologic Pathology ·Wolfgang Kaufmann, Brad Bolon, Alys Bradley, Mark T. Butt, Stephanie Czasch, Robert H. Garman, C. George, Sibylle Gröters, G. Krinke, Peter B. Little, Jenny McKay, Isao Narama, Deepa B. Rao, Makoto Shibutani, Robert C. Sills	2012	93
3	Reprint: Six-Month Continuous Intraputamenal Infusion Toxicity Study of Recombinant Methionyl Human Glial Cell Line-Derived Neurotrophic Factor (r-metHuGDNF) in Rhesus Monkeys Toxicologic Pathology ·David N. Hovland, Robert B. Boyd, Mark T. Butt, Jeffery A. Engelhardt, Michael Moxness, Herbert Mark, Maurice G. Emery, N. Ernst, Randall P. Reed, Jillynne R. Zeller, Don M. Gash, Donna Masterman, B. Potter, Mary Ellen Cosenza, Ruth M. Lightfoot	2007	85
4	Assessment of the Effects of MPTP and Paraquat on Dopaminergic Neurons and Microglia in the Substantia Nigra Pars Compacta of C57BL/6 Mice PLoS ONE ·Richard J. Smeyne, Charles B. Breckenridge, Melissa J. Beck, Yun Jiao, Mark T. Butt, Jeffrey C. Wolf, Dan Zadory, Daniel J. Minnema, Nicholas C. Sturgess, Kim Z. Travis, Andrew R. Cook, Lewis L. Smith, Philip A. Botham	2016	78
5	Nonclinical evaluation of CNS-administered TPP1 enzyme replacement in canine CLN2 neuronal ceroid lipofuscinosis Molecular Genetics and Metabolism ·Brian R. Vuillemenot, Derek Kennedy, Jonathan D. Cooper, Andrew M.S. Wong, Sarmi Sri, Thom Doeleman, Martin L. Katz, Joan R. Coates, Gayle C. Johnson, Randall P. Reed, Eric Adams, Mark T. Butt, Donald G. Musson, Joshua Henshaw, Steve Keve, Rhea Cahayag, Laurie Tsuruda, Charles O’Neill	2014	49
6	Multimodal Perineural Analgesia with Combined Bupivacaine-Clonidine-Buprenorphine-Dexamethasone: Safe In Vivo and Chemically Compatible in Solution Pain Medicine ·Brian A. Williams, Mark T. Butt, Jillynne R. Zeller, Samantha Coffee, Michael A. Pippi	2014	48
7	Characterization of AAV-mediated dorsal root ganglionopathy Molecular Therapy — Methods & Clinical Development ·Nicholas Buss, Lisa G. Lanigan, Jillynne Zeller, Derek D. Cissell, Monica Metea, E. Adams, Mikayla Higgins, Kwi Hye Kim, Ewa Budzynski, Lin Yang, Ye Liu, Mark T. Butt, Olivier Danos, Michele Fiscella	2022	46
8	STP Position Paper: Recommended Best Practices for Sampling, Processing, and Analysis of the Peripheral Nervous System (Nerves and Somatic and Autonomic Ganglia) during Nonclinical Toxicity Studies Toxicologic Pathology ·Brad Bolon, G. Krinke, Mark T. Butt, Deepa B. Rao, Ingrid D. Pardo, Bernard S. Jortner, Robert H. Garman, Karl F. Jensen, Lydia Andrews-Jones, James P. Morrison, Alok Sharma, Michael S. Thibodeau	2018	43
9	Safety Evaluation of Chronic Intrathecal Administration of Idursulfase-IT in Cynomolgus Monkeys Toxicologic Pathology ·B. Felice, Teresa L. Wright, Robert B. Boyd, Mark T. Butt, Richard W. Pfeifer, Jing Pan, Juan Ruiz, Michael W. Heartlein, Pericles Calias	2011	37
10	Pharmacokinetic, neurochemical, stereological and neuropathological studies on the potential effects of paraquat in the substantia nigra pars compacta and striatum of male C57BL/6J mice NeuroToxicology ·Charles B. Breckenridge, Nicholas C. Sturgess, Mark T. Butt, Jeffrey C. Wolf, Dan Zadory, Melissa J. Beck, James M. Mathews, Merrill O. Tisdel, Daniel J. Minnema, Kim Z. Travis, Andrew R. Cook, Philip A. Botham, Lewis L. Smith	2013	36
11	Iatrogenic Transmission of Cytauxzoon felis from a Florida Panther (Felix concolor coryi) to a Domestic Cat Journal of Wildlife Diseases ·Mark T. Butt, Dwight D. Bowman, Margaret C. Barr, Melody E. Roelke	1991	36
12	Determination of the number of mast cells in lymph node, bone marrow, and buffy coat cytologic specimens from dogs Journal of the American Veterinary Medical Association ·Paul F. Bookbinder, Mark T. Butt, Hugh Harvey	1992	34
13	Recombinant human tripeptidyl peptidase-1 infusion to the monkey CNS: Safety, pharmacokinetics, and distribution Toxicology and Applied Pharmacology ·Brian R. Vuillemenot, Derek Kennedy, Randall P. Reed, Robert B. Boyd, Mark T. Butt, Donald G. Musson, Steve Keve, Rhea Cahayag, Laurie Tsuruda, Charles O’Neill	2014	31
14	Morphologic Changes Associated with Intrathecal Catheters for Direct Delivery to the Central Nervous System in Preclinical Studies Toxicologic Pathology ·Mark T. Butt	2010	31
15	Six-Month Continuous Intraputamenal Infusion Toxicity Study of Recombinant Methionyl Human Glial Cell Line-Derived Neurotrophic Factor (r-metHuGDNF) in Rhesus Monkeys Toxicologic Pathology ·David N. Hovland, Robert B. Boyd, Mark T. Butt, Jeffery A. Engelhardt, Michael Moxness, H Mark, Maurice G. Emery, N. Ernst, Randall P. Reed, Jillynne R. Zeller, Don M. Gash, Donna Masterman, B. Potter, Mary Ellen Cosenza, Ruth M. Lightfoot	2007	29
16	Compilation of International Regulatory Guidance Documents for Neuropathology Assessment During Nonclinical General Toxicity and Specialized Neurotoxicity Studies Toxicologic Pathology ·Brad Bolon, Alys Bradley, Mark T. Butt, Karl F. Jensen, G. Krinke, R. Daniel Mellon	2010	26
17	From the Cover: Evaluation of the Effects of Tanezumab, a Monoclonal Antibody Against Nerve Growth Factor, on the Sympathetic Nervous System in Adult Cynomolgus Monkeys (Macaca fascicularis): A Stereologic, Histomorphologic, and Cardiofunctional Assessment Toxicological Sciences ·Patrice C. Bélanger, Paul Butler, Mark T. Butt, Siddhartha Bhatt, Stephen Foote, David L. Shelton, Mark G. Evans, Rosalinda H. Arends, Susan Hurst, Carlin V. Okerberg, Thomas Cummings, David M. Potter, Jill Steidl‐Nichols, Mark Zorbas	2017	25
18	A multiple-dose toxicity study of tanezumab in cynomolgus monkeys Regulatory Toxicology and Pharmacology ·Mark Zorbas, Susan Hurst, David L. Shelton, Mark Evans, Deborah Finco, Mark T. Butt	2010	24
19	Safety Evaluation of CNS Administered Biologics—Study Design, Data Interpretation, and Translation to the Clinic Toxicological Sciences ·Brian R. Vuillemenot, Sven Korte, Teresa L. Wright, Eric Adams, Robert B. Boyd, Mark T. Butt	2016	24
20	Comparative Pathology of the Peripheral Nervous System Veterinary Pathology ·Lisa G. Lanigan, Duncan S. Russell, Kevin Woolard, Ingrid D. Pardo, Virginia Godfrey, Bernard S. Jortner, Mark T. Butt, Brad Bolon	2020	24

About Mark T. Butt

Mark T. Butt is a scholar working on Small Animals, Developmental Neuroscience, Cellular and Molecular Neuroscience, Immunology and Neurology, having authored 62 papers that have together received 1.3k indexed citations. Recurring topics across this work include Immunotoxicology and immune responses (15 papers), Animal testing and alternatives (11 papers), Nerve injury and regeneration (7 papers), Pain Mechanisms and Treatments (6 papers), Neuroscience and Neuropharmacology Research (6 papers), Glycogen Storage Diseases and Myoclonus (6 papers), Lysosomal Storage Disorders Research (5 papers) and Parkinson's Disease Mechanisms and Treatments (5 papers). The work is most often cited by research in Small Animals (261 citations), Developmental Neuroscience (76 citations), Cellular and Molecular Neuroscience (304 citations), Immunology (297 citations) and Neurology (198 citations). Mark T. Butt has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Brad Bolon, Alys Bradley, Robert H. Garman, Ingrid D. Pardo, Karl F. Jensen, Robert B. Boyd, Robert C. Sills, G. Krinke, Ann Radovsky and Deepa B. Rao. Their work appears in journals such as Toxicologic Pathology, Regulatory Toxicology and Pharmacology, Toxicological Sciences, Journal of the American Veterinary Medical Association and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact